# WizeCare — Verify Report (post-resolve re-verification, with Quality read)

### Quality read (current deck)

**Overall: Almost there.** The deck now reads as finished, deliberate work rather than the
unfinished draft the synthesis described. Slide 0 is filled and owned; the research-pivot
beat (Slide 3, "stopped asking and started watching") is the strongest moment and lands as
senior judgment; the card-pattern thesis is surfaced as the spine across patient view /
editor / builder (Slides 10, 13); and the two beats the synthesis named as missing —
`directions` (Ideation, Slide 10) and `reflection` (Slide 15) — are present, with the
reflection honestly owning the late error-rate baseline. Voice is consistently first-person
and de-jargoned (contextual inquiry, Kanban, modal overlays all glossed in plain English).
What keeps it from "ready to send" is provenance, not craft: four credibility-bearing names
are still drafted placeholders, and the outcome metrics — though designer-confirmed real —
are presented without an on-slide n/baseline/timeframe a reader can actually see.

**Seniority: Senior** vs target Senior — reads at target. The constraint-aware goals ("I
could only reorganize, not hide"), the explicit trade-offs (cut animations to ship; inline
editing over pop-ups with the user-quote rationale), the rejected directions with reasons,
and the reflection that names what couldn't be measured are all Senior signals. This is no
longer the "Mid reading toward Senior" of the synthesis — the resolve pass closed that gap.
The one thing that could still pull the read down is unverified specifics reading as
unsupported if a sharp interviewer probes them.

**What's still missing (top 3 concrete gaps):**
1. **The four drafted clinician names** (Maya Levi, Noa Avraham, Tomer Shapira, Yael
   Mizrahi — Slides 3 + 12). They attribute the deck's emotional core (direct research
   quotes) but are placeholder Israeli names. Swap for the real clinicians or relabel as
   "representative" — until then the attribution can't be trusted.
2. **On-slide grounding for the outcome metrics** (Slide 14). The 10–15 min / 75% / 80% are
   confirmed real, but the slide shows no sample size, baseline, or window beyond soft
   hedges ("per stakeholder report," "usability-test baseline"). Add n and timeframe inline
   so the numbers read as evidence, not assertions — the difference between "impressive" and
   "credible" for a Senior reader.
3. **The 80% adoption metric is a bare percentage with no denominator.** The reflection
   already concedes the misclick gain leans on post-launch numbers alone; the outcomes slide
   would read stronger if 80% carried even a rough "X of Y former non-users" so the headline
   number isn't the one thing a reader has to take on faith.

---

### Verdict: PASS

Correctness only: no agent-invented unflagged fabrications and no cross-slide contradictions.
The resolve pass only removed/softened claims and used drafted names already recorded in
`confirmed.md`. The four drafted names are settled placeholders → Verify-before-sending, not
blocking.

### Blocking issues (pipeline must auto-fix)
None.

Resolve-edit integrity check (all clean, verified against the extracted text + `confirmed.md`):
- **Slide 0** — former "80%" headline metric gone; the slide-14 ↔ slide-0 duplicated line is
  resolved with no dangling reference. ✓
- **Slide 1** — no "Sarah", no "15 min / 12+ patients" quote, no "30%"; genericized to an
  unnamed clinician as intended. ✓
- **Slide 14** — three metrics only (10–15 min, 75%, 80%); the "55% drop in support tickets"
  stat is removed, with no orphaned reference elsewhere. ✓
- **Counts consistent** after the edits — interviews 8 (slides 2/3/5), clinics 6 (slides
  2/3/5), 89 tickets / 8 weeks (slide 2). The 12-vs-8 conflict the synthesis flagged is
  reconciled; no new contradiction introduced. ✓
- **80% appears once** (slide 14) with a coherent back-reference in the slide-15 reflection
  ("whether the 80% adoption holds past month one") — supportive, not contradictory. ✓
- **No "Senior"/"SaaS" self-labeling** added anywhere; positioning kept soft per the
  `confirmed: false` flags. ✓

### Verify before sending (designer's call — NOT blocking)
Per `confirmed.md`, the 89 tickets / 6 clinics / 8 interviews / 12-week timeline / team /
role / and the three slide-14 outcome metrics (10–15 min, 75%, 80%) are CONFIRMED REAL and
are deliberately NOT listed here. What remains is only the drafted placeholder names:

- **Slide 3** · `[slides.3.quotes.0.author]` · "Noa Avraham, physiotherapist" · drafted
  Israeli name — replace with the real clinician or keep as representative.
- **Slide 3** · `[slides.3.quotes.1.author]` · "Tomer Shapira, physiotherapist" · drafted —
  replace with the real clinician or keep as representative.
- **Slide 3** · `[slides.3.quotes.2.author]` · "Yael Mizrahi, physiotherapist" · drafted —
  replace with the real clinician or keep as representative.
- **Slide 12** · `[slides.12.author]` · "Maya Levi" · drafted — swap for the real clinician
  or keep as representative.

(The quote *text* on slides 3 and 12 is the designer's own research wording — kept; only the
attributed names are drafted placeholders.)

### Nits (auto-fixable, listed for transparency)
Over-budget slides (pre-existing, not introduced by resolve; pipeline trims toward budget):
- **Slide 2** — 105 vs ~95. ⚠
- **Slide 3** — 136 vs ~110. ⚠ (heaviest)
- **Slide 9** — 128 vs ~110. ⚠
- **Slide 13** — 132 vs ~110. ⚠

All other slides within budget. (Slide 0 title is 8 words; renders large and doesn't break
the canvas — copy-summary already notes the drop-"everyday" 7-word fallback.)
Minor voice nit: the three Slide-14 metric descriptions each end on a soft hedge ("per
stakeholder report" / "in post-launch validation" / "against the usability-test baseline") —
honest, but three in a row reads slightly defensive; vary the phrasing.

### Leaning on unconfirmed profile values
None. The card-pattern thesis (slides 0, 13) stays as plain description, not asserted as a
branded "signature" or a seniority claim; no "Senior"/"SaaS" labels appear in the prose. The
`confirmed: false` positioning is not hardened anywhere.

### Confidence
Safe to show once the four drafted clinician names (slides 3, 12) are confirmed or relabeled.
No correctness blocker remains — the deck is internally consistent, jargon-free, first-person,
and the resolve edits landed cleanly. The over-budget comparison/quote slides auto-trim in the
pipeline; they are not designer decisions.
